Source:http://linkedlifedata.com/resource/pubmed/id/17825025
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-9-10
|
pubmed:abstractText |
Statistical validation of a surrogate marker has been studied for more than a decade. Recently, Alonso et al. (2004, Biometrics 60, 724-728) proposed a quantity called the likelihood reduction factor (LRF) to evaluate the validity of a surrogate marker. However, as pointed out in the present article, the LRF may not correctly validate a surrogate marker. Therefore, a new quantity, the proportion of information gain (PIG) using the Kullback-Leibler information, is proposed. Simulations show that under some model assumptions, the PIG precisely reflects the role of a surrogate marker.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-341X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
958-62; author reply 962-3
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17825025-Biometry,
pubmed-meshheading:17825025-Clinical Trials as Topic,
pubmed-meshheading:17825025-Endpoint Determination,
pubmed-meshheading:17825025-Humans,
pubmed-meshheading:17825025-Interferon Type I,
pubmed-meshheading:17825025-Likelihood Functions,
pubmed-meshheading:17825025-Macular Degeneration,
pubmed-meshheading:17825025-Meta-Analysis as Topic,
pubmed-meshheading:17825025-Models, Statistical,
pubmed-meshheading:17825025-Recombinant Proteins,
pubmed-meshheading:17825025-Visual Acuity
|
pubmed:year |
2007
|
pubmed:articleTitle |
Quantifying the effect of the surrogate marker by information gain.
|
pubmed:affiliation |
Eli Lilly and Company, Indianapolis, Indiana 46285, USA. qu_yongming@lilly.com
|
pubmed:publicationType |
Journal Article,
Comment
|